Pro-DexFRA:PDXN 63 FCF Margin % is 8.19% as of Mar. 2026, which is 2% below its 10-year median of 8.36. GuruFocus rates FRA:PDXN with a GF Score™ of 63/100 and a GF Value™ of €37.92 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Pro-Dex ranks better than 73.25% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pro-Dex's Free Cash Flow for the
three
months ended in Mar. 2026 was €1.41 Mil. Pro-Dex's Revenue for the
three
months ended in Mar. 2026 was €17.26 Mil. Therefore, Pro-Dex's FCF Margin % for the quarter that ended in Mar. 2026 was 8.19%.
The historical rank and industry rank for Pro-Dex's FCF Margin % or its related term are showing as below:
FRA:PDXN'
s FCF Margin % Range Over the Past 10 Years
Min: -27.31 Med: 8.36 Max: 12.57
Current: 9.79
During the past 13 years, the highest FCF Margin % of Pro-Dex was 12.57%. The lowest was -27.31%. And the median was 8.36%.
FRA:PDXN's FCF Margin % is ranked better than 73.25% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:PDXN: 9.79
Pro-Dex FCF Margin % Related Terms
Pro-Dex FCF Margin % Historical Data
* Premium members only.
The historical data trend for Pro-Dex's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDXN vs SMTI, UTMD, EMBC: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Pro-Dex's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro-Dex (FRA:PDXN) has a FCF Margin % of 8.19% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pro-Dex and its competitors. This is near median its historical median of 8.36. According to the industry distribution chart, Pro-Dex ranks #218 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 26.7%.
Is Pro-Dex's FCF Margin % too high?
Pro-Dex's current FCF Margin % of 8.19% is near median its 10-year median of 8.36. Based on the distribution chart, Pro-Dex ranks #218 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pro-Dex has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's FCF Margin % compare to SMTI and UTMD?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #218 out of 815 companies for FCF Margin %. This puts Pro-Dex in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pro-Dex and its competitors. Pro-Dex's current FCF Margin % is 8.19%, which is near median its own 10-year median of 8.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €37.92, compared to a current price of €57.00 — trading 50.3% above its estimated fair value. The current FCF Margin % is 8.19%, which is near median its 10-year median of 8.36. Pro-Dex's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current FCF Margin % is 8.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (FRA:PDXN) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of €57.00 is trading 50.3% above its estimated GF Value™ of €37.92.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for FRA:PDXN:
FCF Margin %: 8.19% (near median its 10-year median of 8.36)
GF Value™: €37.92 vs. price of €57.00 (50.3% above fair value)
No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
63GF Score
Get the complete analysis for FRA:PDXN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDXN has been successfully added to your 
